MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Structural-Functional Coupling Supporting Motor Reserve in Early-Stage Parkinson’s Disease

    Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)

    Objective: To explore whether motor reserve in early Parkinson's disease (PD) is related to structural-functional coupling (SFC) Background: Motor reserve contributes to individual variability in…
  • 2026 International Congress

    Elucidating the demographic distributions and implications of GBA1 gene variants in Parkinson’s Disease.

    F. Fraser, M. Toffoli, G. Pittwood, A. Anderson, J. Stepniak, A. Schapira (London, United Kingdom)

    Objective: Estimating the distribution of GBA1 variants and estimating GBA1 odds ratios for Parkinson’s disease in the UK-based population. Background: Mutations in GBA1 are an…
  • 2026 International Congress

    Environmental Risk Factor Co-Exposure as Drivers of Parkinson’s Disease Development: A Scoping Review

    A. Mcnamara, K. Daminato, L. Collins-Praino (Adelaide, Australia)

    Objective: To map and synthesise epidemiological evidence assessing environmental co-exposures and Parkinson’s disease (PD) risk Background: PD is a multifactorial neurodegenerative disorder attributed to genetic,…
  • 2026 International Congress

    Neural Network Reorganization Mediates the Analgesic Effects of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease

    C. Mao, M. Liu, Y. Luo, Y. Zhang, E. Wang, X. Cheng, J. Zhang, F. Wang, C. Liu (Suzhou, China)

    Objective: To evaluate the efficacy of high-frequency M1-rTMS for musculoskeletal pain in PD and investigate its underlying neurophysiological mechanisms using multimodal electrophysiology and imaging. Background:…
  • 2026 International Congress

    Clinical Profile and Progression of Parkinson’s Disease in Nigerians with the GBA1 African Ancestry-specific Risk Variant

    O. Ojo, N. Okubadejo, NPD. Research Network, GP2. Genetics Program (Lagos, Nigeria)

    Objective: This study compares clinical features and disease progression across rs3115534 genotypes (G/G, G/T, T/T) in Nigerians with Parkinson's disease (PD). Background: Variants in GBA1 are major…
  • 2026 International Congress

    Trancranial Sonography Reveals Striatal Neurodegeneration in the Prodromal Phase of X-linked Dystonia-Parkinsonism

    M. Pauly, C. Diesta, P. Cataniag, M. Borsche, H. Hanssen, J. Ong, JQ. Oropilla, U. Walter, D. Dressler, S. Algodon, A. Westenberger, C. Klein, N. Brüggemann (Lübeck, Germany)

    Objective: To use transcranial sonography (TCS) to detect striatal and substantia nigra abnormalities in patients with X-linked dystonia-parkinsonism syndrome (XDP), non-manifesting carriers (NMC) of the…
  • 2026 International Congress

    A Diffusion MRI Neurodegeneration Index for Lewy Body Dementia & Alzheimer’s disease

    S. Chiu, R. Chen, W. Wang, J. Desimone, A. Barmpoutis, M. Armstrong, D. Vaillancourt (Scottsdale, USA)

    Objective: To develop a diffusion MRI-based neurodegeneration index using free-water imaging and assess its ability to quantify neurodegenerative burden in Lewy body dementia (LBD) and…
  • 2026 International Congress

    Dysregulation of the Intestinal Macrophage CXCL8/CXCR2 Axis and Its Role in α-Synuclein Clearance

    H. Hu, T. Tang, W. Wang (Shanghai, China)

    Objective: To investigate the role of the CXCL8/CXCL2–CXCR2 axis in intestinal macrophage-mediated clearance of α-syn in PD. Background: PD is characterized by the misfolding, aggregation,…
  • 2026 International Congress

    Perplexing Presentation of Myasthenia Gravis in an Elderly Patient with Essential Tremor and Parkinson’s Disease Complex Case Report

    I. Eltazi, B. Canibano, O. Suliman (Doha, Qatar)

    Objective: To highlight a complex clinical case of coexisting movement and neuromuscular junction (NMJ) disorders. Background: Essential tremor (ET) is the most common movement disorder…
  • 2026 International Congress

    Does Knowing More Mean Tolerating More? Satisfaction with Medication Information and Levodopa Dosage in Parkinson’s Disease

    M. da Silva, M. Tosin, L. Silveira-Moriyama (Campinas, Brazil)

    Objective: To characterize the correlation between satisfaction with medication-related information and daily levodopa dosage in Parkinson’s disease (PD) patients presenting with levodopa-related complaints. Background: Adequate…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley